PREVYMIS
ItalyThe drug is used for the treatment of HIV and cytomegalovirus.
Frequently asked questions
How should PREVYMIS be taken?
The method of administration depends on the pharmaceutical form (tablets, sachets, or solution for infusion) and the patient's body weight. Tablets or sachets may be taken once daily, while the solution can be administered intravenously.
What is the dosage of PREVYMIS based on weight?
The dosage varies depending on body weight and the form of the drug. For example, for tablets, a patient weighing 30 kg or more may take 480 mg (one 480 mg tablet or two 240 mg tablets), while a patient weighing between 15 kg and less than 30 kg takes 240 mg.
What should I do if a dose is forgotten?
In case of a missed dose, it is necessary to consult the instructions provided by healthcare personnel or the nurse.
What are the possible side effects?
The drug may cause some adverse effects; it is important to consult the specific section of the package leaflet for the complete list.
Instructions for use
- to the nurse
- to the nurse
What is
What is
("cytomegalovirus").
- or or
- or
to the nurse
or
or
"Other PREVYMIS"
of the other
the list
' "
"
- used for the treatment of HIV
Breastfeeding the intake
" "
'
until the effect does not
" "
| Body weight | Daily oral dose of PREVYMIS | Number of PREVYMIS tablets once daily |
| 30 kg and above | 480 mg | One 480 mg tablet or Two 240 mg tablets |
| 15 kg to less than 30 kg | 240 mg | One 240 mg tablet |
| Body weight | Daily oral dose of PREVYMIS | Number of PREVYMIS tablets once daily |
| 30 kg and above | 240 mg | One 240 mg tablet |
| 15 kg to less than 30 kg | 120 mg | See the package leaflet of PREVYMIS granules in sachets |
- a little water
- at the scheduled time
- the administration the administration
on the use
to the nurse.
- '
to the nurse
reported in the '
to the latest
'
'
the environment.
"lactose" "PREVYMIS sodium".
of the ASP
("tablet")
"591" on the other.
("tablet")
"595" on the other.
of the marketing authorization to the placing
of the marketing authorization to the placing
България
Merck Sharp & Dohme Bulgaria EOOD
Tel.: +359 2 819 3737
Česká republika
Ελλάδα
A.F.E.E.
Tel
á
Κύπρος
Tel.: 800 00 673 (+357 22866700)
of the Agency
- to the nurse.
- to the nurse.
What is
What is
("cytomegalovirus").
- or or
- or
to the nurse
or
or
"Other PREVYMIS")
of the other
the list
").
' "
"
- for the treatment of HIV
Breastfeeding the administration
'
until the
ll'1.15'
'
| Body weight | Daily intravenous dose without cyclosporine | Daily intravenous dose with cyclosporine |
| 30 kg and above | 480 mg | 240 mg |
| Body weight | Daily intravenous dose without or with cyclosporine | |
| from 15 kg to less than 30 kg | 120 mg | |
| from 7.5 kg to less than 15 kg | 60 mg | |
| from 5 kg to less than 7.5 kg | 40 mg | |
If you miss the appointment for administration of
- the appointment
on use
to the nurse.
- '
to the nurse.
brought in the '
at the last
'
'
'
'
'
the environment.
" "
"PREVYMIS".
of the appearance
of the marketing authorization
of the marketing authorization
България
Merck Sharp & Dohme Bulgaria Ltd
Tel.: +359 2 819 3737
Česká republika
Ελλάδα
A.F.E.E.
Tel
á
Κύπρος
Tel.: 800 00 673 (+357
of the Agency
the use
of the use
| Intravenous dose | Volume of 20 mg/mL PREVYMIS concentrate for solution for infusion | Final infusion volume | Final letermovir concentration |
| 120 mg | 6 mL of 20 mg/mL | 75 mL | 1.6 mg/mL |
| 60 mg | 3 mL of 20 mg/mL | 50 mL | 1.2 mg/mL |
| Intravenous dose | Dilution volume of PREVYMIS 2 mg/mL (1:10)* | Final infusion volume | Final letermovir concentration |
| 40 mg | 20 mL of 2 mg/mL | 20 mL | 2 mg/mL |
| * To prepare the PREVYMIS 2 mg/mL dilution, add 5 mL of PREVYMIS 20 mg/mL concentrate for solution for infusion from the vial to 45 mL of diluent (sodium chloride 9 mg/mL (0.9%) or 5% dextrose) and gently mix. | |||
-
inside
-
the entire
-
•
-
•
-
•
-
•
-
•
-
•
-
•
-
•
-
•
-
•
-
•
-
•
-
•
-
•
-
to the nurse.
-
to the nurse.
What is
What is
("cytomegalovirus").
- or or
- or
to the nurse
or
or
"Other PREVYMIS"
of the other
the list
' "
"
- for the treatment of HIV
Breastfeeding the intake
4 "Possible side effects" below). Some patients have
'
until the effect does not
"
"
| Body weight | Daily oral dose of PREVYMIS | Number of PREVYMIS sachets once daily |
| 30 kg and above | 480 mg | Four 120 mg sachets |
| 15 kg to less than 30 kg | 240 mg | Two 120 mg sachets |
| 7.5 kg to less than 15 kg | 120 mg | One 120 mg sachet |
| 5 kg to less than 7.5 kg | 80 mg | Four 20 mg sachets |
| Body weight | Daily oral dose of PREVYMIS | Number of PREVYMIS sachets once daily |
| 30 kg and above | 240 mg | Two 120 mg sachets |
| Body weight | Daily oral dose of PREVYMIS | Number of PREVYMIS sachets once daily |
| 15 kg to less than 30 kg | 120 mg | One 120 mg sachet |
| 7.5 kg to less than 15 kg | 60 mg | Three 20 mg sachets |
| 5 kg to less than 7.5 kg | 40 mg | Two 20 mg sachets |
- use '
- at the time of
- '
- taking taking
on use
to the nurse.
- '
to the nurse
in the '
in the last
in water
the environment.
"PREVYMIS lactose" "PREVYMIS sodium".
of the appearance
- of the authorization to placing on the market
of the authorization to placing on the market
България
Merck Sharp & Dohme Bulgaria EOOD
Tel.: +359 2 819 3737
Česká republika
Ελλάδα
A.F.E.E.
Tel
á
Κύπρος
Tel.: 800 00 673 (+357 22866700)
of the Agency
Instructions for use
on use
These "Instructions for use" contain information on how to take PREVYMIS
- or
- or
- or
or
or
'.
- Refer to the section "Mixing with food ".
- Refer to the section "Administering ".
- or
- or
- towards the
'
For further information, refer to the sections "Co
" and "
PREVYMIS".
or
or
- or
or
- '
'
- towards the
'
- minutes, the mixture will be ready for use.
'
- or shake the syringe to avoid formation of air bubbles.
'
and pull up the plunger of the
- or shake the syringe to avoid formation of air bubbles.
- or or
- For further information, refer to the sections "Co " and " PREVYMIS".
'
The original data is available in the language of the country of manufacture.
Data source: Italian Medicines Agency (AIFA)
Data last verified: September 21, 2026